InPrint is a lightweight, thin-film metal temporary tattoo that tracks tremors and drug usage for Parkinson’s patients. Parkinson’s is the second most common neurodegenerative disease and it can take up to six months for patients to find an effective drug regimen. Neurologists often change a patient’s treatment plan every two to three years due to the disease’s progression and have no way of accurately monitoring their symptoms during these transition periods. Applied onto the skin like a sticker, InPrint offers an accessible, low-cost method of detecting tremors while recording their duration and severity. By using the connected InPrint mobile app, patients can set medication reminders and input their drug intake while neurologists can evaluate patient symptoms to create a personalized medication schedule. Not only does InPrint make it easier to precisely monitor tremors, it can also shorten the six-month period typically needed to create a stable drug regimen.
Lumenda
In developing countries, the cost to diagnose meningitis remains high and therefore many neonates are denied quality healthcare. Approximately 126,000 cases of neonatal bacterial meningitis
May 10, 2018
